Findlay Park Partners LLP Invests $92.08 Million in The Cooper Companies, Inc. $COO

Findlay Park Partners LLP purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO) during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 1,284,000 shares of the medical device company’s stock, valued at approximately $92,076,000.

Other large investors also recently added to or reduced their stakes in the company. Root Financial Partners LLC grew its position in shares of Cooper Companies by 104.5% in the fourth quarter. Root Financial Partners LLC now owns 317 shares of the medical device company’s stock valued at $26,000 after purchasing an additional 162 shares during the period. Avalon Trust Co purchased a new position in Cooper Companies in the 2nd quarter valued at about $25,000. SJS Investment Consulting Inc. boosted its holdings in Cooper Companies by 107.5% in the 1st quarter. SJS Investment Consulting Inc. now owns 361 shares of the medical device company’s stock worth $26,000 after buying an additional 187 shares during the last quarter. Elevation Wealth Partners LLC boosted its holdings in Cooper Companies by 1,136.4% in the 2nd quarter. Elevation Wealth Partners LLC now owns 408 shares of the medical device company’s stock worth $29,000 after buying an additional 375 shares during the last quarter. Finally, J.Safra Asset Management Corp acquired a new position in shares of Cooper Companies during the second quarter valued at approximately $32,000. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on the company. JPMorgan Chase & Co. lowered their price target on Cooper Companies from $80.00 to $71.00 and set a “neutral” rating on the stock in a research note on Friday, June 5th. UBS Group began coverage on shares of Cooper Companies in a research note on Tuesday, July 28th. They set a “neutral” rating and a $75.00 target price on the stock. Piper Sandler set a $86.00 target price on shares of Cooper Companies and gave the company an “overweight” rating in a research report on Monday, June 1st. Mizuho set a $85.00 price target on shares of Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, June 4th. Finally, Stifel Nicolaus dropped their price objective on shares of Cooper Companies from $95.00 to $85.00 and set a “buy” rating for the company in a research note on Friday, June 5th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, six have given a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Cooper Companies has a consensus rating of “Hold” and an average target price of $81.64.

Cooper Companies Price Performance

Shares of COO stock opened at $76.22 on Friday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The company has a market capitalization of $14.87 billion, a PE ratio of 64.59, a price-to-earnings-growth ratio of 1.99 and a beta of 0.83. The firm’s 50-day moving average is $71.93 and its two-hundred day moving average is $71.16. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share for the quarter, beating the consensus estimate of $1.10 by $0.11. The business had revenue of $1.08 billion during the quarter, compared to analysts’ expectations of $1.05 billion. Cooper Companies had a net margin of 5.57% and a return on equity of 10.88%. The business’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Analysts predict that The Cooper Companies, Inc. will post 4.63 earnings per share for the current year.

About Cooper Companies

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.